- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07758998
The Effect of Motivational Interviewing on Smoking Behavior Among Nursing Students
The Effect of Motivational Interviewing on Changing Smoking Behavior Among Nursing Students
Smoking is one of the leading preventable public health problems worldwide, particularly among young adults who are at increased risk of nicotine dependence. Nursing students represent an important target population because, as future health professionals, they are expected to play a significant role in tobacco control and smoking cessation counseling. The Transtheoretical Model (TTM) is one of the most widely used theoretical frameworks for promoting health behavior change. The aim of this study will be to determine the effect of Transtheoretical Model-based motivational interviewing on changing smoking behavior among nursing students.
This study will be planned as a single-group, quasi-experimental pretest-posttest intervention. Nursing students who smoke cigarettes and voluntarily agree to participate will be included in the study. At baseline, participants will complete a Demographic Information Form, the Fagerström Test for Nicotine Dependence, the Stages of Change questionnaire, the Self-Efficacy/Temptation Scale, the Processes of Change Scale, and the Decisional Balance Scale.
Participants will receive Transtheoretical Model-based educational sessions and motivational interviewing interventions focusing on the health effects of smoking, reasons for smoking, the benefits of smoking cessation, identification of social support resources, relapse prevention strategies, and successful smoking cessation experiences. The Stages of Change questionnaire will be administered before each motivational interviewing session, and all outcome measures will be reassessed during follow-up evaluations. The study is expected to provide evidence regarding the effectiveness of Transtheoretical Model-based motivational interviewing in reducing smoking behavior, decreasing nicotine dependence, promoting progression through the stages of change, improving self-efficacy, enhancing the use of behavioral change processes, and supporting smoking cessation among nursing students.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Sevim Meral Feratoğlu, MSc
- Numéro de téléphone: +905346674614
- E-mail: sevimmeralf@outlook.com
Lieux d'étude
-
-
Kırklareli
-
Kırklareli, Kırklareli, Turquie (Türkiye), 39100
- Kırklareli University Faculty of Health Sciences
-
Contact:
- Sevim Meral Feratoğlu, MSc
- Numéro de téléphone: +905346674614
- E-mail: sevimmeralf@outlook.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Nursing students currently enrolled in the study setting.
- Aged 18 years or older.
- Current cigarette smokers.
- No self-reported health condition that would prevent participation in the intervention.
- Willing and able to provide informed consent and participate in the study.
Exclusion Criteria:
- Inability to complete all planned stages of the study.
- Withdrawal of consent or voluntary discontinuation from the study at any time.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Motivational Interviewing
Participants will receive a Transtheoretical Model-based motivational interviewing intervention designed to promote smoking behavior change and smoking cessation.
The intervention will consist of structured face-to-face motivational interviewing sessions delivered in groups, supported by educational content on the health effects of smoking, benefits of smoking cessation, behavior change strategies, social support, relapse prevention, and self-efficacy enhancement.
Outcomes will be evaluated using validated questionnaires administered at baseline and follow-up assessments.
|
Participants will receive a Transtheoretical Model-based motivational interviewing intervention to promote smoking behavior change and smoking cessation.
Face-to-face motivational interviewing sessions will be conducted by a researcher trained in motivational interviewing.
According to the intervention protocol, participants may receive between two and six sessions depending on their readiness to change, individual needs, and continued participation throughout the study.
The intervention will include counseling and education on smoking-related health risks, smoking cessation, motivation enhancement, self-efficacy, behavior change strategies, social support, and relapse prevention.
Participants' stage of change will be assessed before each session, and the intervention will be tailored accordingly.
Outcomes will be evaluated using validated instruments measuring smoking behavior, nicotine dependence, stages of change, self-efficacy, and behavior change processes.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Smoking Behavior
Délai: Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)
|
The primary outcome is the change in smoking behavior following the Transtheoretical Model-based motivational interviewing intervention.
Smoking behavior will be evaluated by the average number of cigarettes smoked per day and smoking cessation status.
|
Baseline, Mid-intervention Assessment (1 month), Post-intervention Assessment (2 months)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Nicotine Dependence
Délai: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Nicotine dependence will be assessed using the Fagerström Test for Nicotine Dependence (FTND).
The total score ranges from 0 to 10, with higher scores indicating a higher level of nicotine dependence.
|
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
|
Change in Processes of Change
Délai: Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
|
Behavioral change processes will be assessed using the Processes of Change Scale.
The total score ranges from 22 to 110, with higher scores indicating greater use of behavioral change processes related to smoking cessation.
|
Baseline, Mid-intervention Assessment( 1 month later), Post-intervention Assessment (2 months later)
|
|
Change in Self-Efficacy/Temptation for Smoking Cessation
Délai: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Self-efficacy related to smoking cessation will be assessed using the Self-Efficacy/Temptation Scale.
The scale consists of 8 items rated on a 5-point Likert scale, with a total score ranging from 8 to 40.
Higher scores indicate greater self-efficacy and greater confidence in the ability to refrain from smoking in situations that may trigger the urge to smoke.
|
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
|
Change in Decisional Balance
Délai: Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Decisional balance related to smoking cessation will be assessed using the Decisional Balance Scale.
The scale consists of 12 items rated on a 5-point Likert scale, with a total score ranging from 12 to 60. Higher scores indicate greater perceived importance of the benefits and barriers of change and greater engagement in the decision-making process related to smoking cessation.
|
Baseline, Mid-intervention Assessment (1 month later), Post-intervention Assessment (2 months later)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- KLU-SMOKE-MI
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .